Latest Market News

Jan 30
Press release on the suspension of trading in Biocartis

ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of Biocartis, ISIN BE0974281132, on Euronext Brussels is suspended from 29/10/2020 at 16:40 CET until the publication of a press release. Source: FSMA

Jan 30
Press release on the suspension of trading in Sioen

ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of Sioen, ISIN BE0003743573, on Euronext Brussels is suspended from 29/10/2020 at 13:00 CET until the publication of a press release.   Source: FSMA

Jan 30
The FSMA provides guidance on information disclosures by biotech companies

This press release is not available in English. Please consult the French or Dutch site. Read the entire opinion here. Source: FSMA

Jan 30
Cyber vigilante hunts down DeFi scammers running away with $25M rug pull

In the world of digital finance, where the weapon of choice for a heist is a computer rather than a semi-automatic firearm, tracking down scams and frauds from across the world becomes a near-impossible feat for centralized police forces.  However, in an interview with Cointelegraph, an anonymous cyber vigilante shares insights into how he went […]

Jan 30
Merck, Ridgeback says COVID-19 pill molnupiravir shows antiviral activity against omicron variant

Merck & Co. Inc. MRK, +0.40% and partner Ridgeback Biotherapeutics said Friday that data from six preclinical studies of its molnupiravir COVID-19 pill showed “consisent antiviral activity” against the omicron variant of the coronavirus that causes COVID-19. The preclinical studies were conducted independently in Belgium, Czech Republic, Germany, Poland, the Netherlands and the U.S. Molnupiravir […]

Jan 30
Colgate expects higher pricing in 2022, launches initiative to drive savings

Colgate-Palmolive Co. CL, +0.42% reported fourth-quarter net income of $148 million, or 18 cents per share, down from $647 million, or 75 cents per share, last year. Adjusted EPS of 79 cents was in line with the FactSet consensus. Sales of $4.403 billion were down from $4.324 billion last year and just missed the FactSet […]